Trial of amantadine in Parkinson's disease
Campbell, A.M.; Williams, M.J.
British Journal of Clinical Practice 26(1): 19-22
1972
ISSN/ISBN: 0007-0947 PMID: 4554563 Document Number: 51793
Document emailed within 1 workday
Related Documents
Griffiths, A.V.; Parker, W.N.; Palmer, R.M. 1971: Experiences with amantadine hydrochloride in Parkinson's disease Practitioner 207(241): 679-680Pendefunda, G.; Pollingher, B.; Stefanache, F.; Gavril, A.; Oprisan, C.; Merling, M.; Nemteanu, E.; Ciunru, M.; Koropitzer, I. 1975: The treatment with L-dopa and amantadine in Parkinson's disease Therapia Hungarica 23(1): 12-16
Danielczyk, W. 1995: Twenty-five years of amantadine therapy in Parkinson's disease Journal of Neural Transmission. Supplementum 46: 399-405
Fasano, V.A.; Urciuoli, R.; Broggi, G. 1971: On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases) Minerva Medica 62(82): 3968-3970
Dzudza, M.; Dzudza, D. 1974: Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease Medicinski Arhiv 28(4): 407-415
Silver, D.E.; Sahs, A.L. 1971: Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease Transactions of the American Neurological Association 96: 307-308
Campanella, G.; Zallone, E.; Buscaino, G.A. 1972: Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months Acta Neurologica 27(5): 491-500
Puca, F.M.; Bricolo, A.; Turella, G. 1972: Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes Revue Neurologique (Paris) 127(2): 313
Gospavić, J.; Vidaković, Z. 1974: Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents Srpski Arhiv Za Celokupno Lekarstvo 102(6): 447-457
Dordain, G.; Goujet, M.A.; Simon, P. 1974: Preliminary clinical trial of tetrahydropapaveroline in Parkinson's disease Therapie 29(3): 421-434
Cubells, J.M.; Hernando, C. 1988: Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease Clinical Therapeutics 10(6): 664-671
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Domenichini, E.; Carbonera, D.; Pagnin, A.; Scherini, A. 1972: Sequential trial upon the awakening effect of amantadine after ketamine anaesthesia Current Therapeutic Research 14(11): 707-710
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Poungvarin, N.; Viriyavejakul, A. 1990: L-deprenyl therapy in Thai patients with Parkinson's disease: before and after, clinical trial of 50 patients Journal of the Medical Association of Thailand 73(7): 381-386
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Mastaglia, F.L.; Masters, C.L.; Beyreuther, K.; Kakulas, B.A. 1989: Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease Progress in Clinical and Biological Research 317: 475-484
Braak, H.; Braak, E.; Yilmazer, D.; de Vos, R.A.; Jansen, E.N.; Bohl, J. 1996: New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease Journal of Neural Transmission. Supplementum 48: 1-6
Schoenberg, B.S. 1987: Descriptive epidemiology of Parkinson's disease: disease distribution and hypothesis formulation Advances in Neurology 45: 277-283